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A biotech corn stirs fresh food
fears, reports Laura Bonetta
Genetically modified (GM) crops
have been at the center of a storm of
protests in Europe, which has begun
to move into the United States. US
surveys show increasing consumer
concern about food biotechnology
and some major food companies have
announced decisions to purchase
only non-bioengineered products.
Recently, the finding of StarLink®
corn in taco shells has raised harsh
criticisms about the adequacy of US
regulations of biotechnology.
StarLink®, a genetically-altered corn
variety produced by Aventis Crop
Science, was approved for animal but
not human consumption out of
concern that it might contain an
allergen. “The assertion that there is
no problem with these products was
undercut substantially by StarLink,”
says Art Jaeger, assistant director for
the Consumer Federation of America
Foundation (CFAF).
In an attempt to maintain public
confidence, the US Food and Drug
Administration (FDA) issued in mid-
January a proposed rule that would
require GM crop developers to notify
FDA of their intent to market a food
or animal feed and provide evidence
that the product is as safe as its
unmodified counterpart. FDA would
post the information submitted by
manufacturers, as well as FDA’s
responses, in the Agency’s electronic
reading room. The FDA, however,
continues to oppose full-fledged
government safety reviews and the
labeling of foods created by
biotechnology. As a result, consumer
groups don’t think FDA’s proposed
changes go far enough. 
Currently, the area planted with
GM crops is growing. More than half
of the world’s soybean crops and
about one third of the corn crops are
transgenic. According to the
International Service for the
Acquisition of Agri-biotech
Applications (ISAAA), from 1996 to
2000 the global area of transgenic
crops increased by more than 25 fold
from 1.7 million hectares to
44.2 million hectares (almost twice
the area of the United Kingdom). In
2000, four countries - US, Argentina,
Canada and China - grew 99% of the
global transgenic crop area.
In the United States, over 40 GM
food crops have completed all the
federal regulatory requirements and
have made their way into thousands
of consumer items. The approval of
such products falls under the
jurisdiction of three government
agencies: the US Department of
Agriculture (USDA), the
Environmental Protection Agency
(EPA), and the FDA. 
The FDA continues to oppose
full-fledged government safety
reviews and the labeling of foods
created by biotechnology…
consumer groups don’t think
FDA’s proposed changes go
far enough
The FDA, whose regulations have
been the primary focus of the ‘public
debate’ over biotechnology, oversee
food and feed derived from new
plant varieties. While the FDA has
the authority to remove a food from
commercialization if it is found to be
unsafe, it does not require safety
testing prior to commercialization.
Pre-market approval is required only
for food additives that are
significantly different from
substances currently found in food.
Most of the GM food crops
developed to date do not, however,
fall in this category.
According to Art Jaeger, GM food
products are not getting much
scrutiny. “Companies are making the
determination of safety not the
FDA,” says Jaeger, who personally
reviewed several FDA files on
bioengineered foods. The FDA
normally closes the consultation
process within a few months by
sending a letter noting that the
company feels that the product is
safe and that the FDA has no further
questions. The onus is on the
company to continue monitoring it.
Up to now determination of the
regulatory status of a product with
the FDA has been voluntary. Under
the new proposed rule, the FDA will
make this process mandatory. The
CFAF, however, wants more
stringent pre-market testing and
monitoring of all GM foods. “We
don’t know the long term effects of
these products,” says Jaeger. 
Proponents of the technology
point out that there has been no
evidence of any negative effects.
Brian Ellis, associate director of the
Biotechnology Laboratory at the
University of British Columbia,
cautions, however, that “it would be
premature to declare a total absence
of adverse effects, since I am
unaware of any systematic
monitoring for such effects in either
the USA or Canada.” Ellis co-chaired
a panel of scientific experts from the
Royal Society of Canada, which
rejected in a report released in
February the doctrine of treating the
approval of GM crops as though they
were much the same as
conventionally grown crops.
Both the testing and monitoring
of GM food crops present technical
and financial challenges and it is
unlikely that any solution will satisfy
both sides of the debate, according to
Christopher Somerville, director of
the Carnegie Institution of
Washington, who served as a
member of the EU–US
Biotechnology Consultative Forum.
“We need to have a regulatory
process that can identify and prevent
any deleterious applications, and
assess each application for risks and
benefits and make risk and benefit
judgments,” says Somerville.
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